Hodgkin's lymphoma: The hazards of success

Journal of Clinical Oncology

Volumn 21, Issue 18, 2003, Pages 3388-3390

  Connors, Joseph M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CAUSE OF DEATH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG MEGADOSE; EDITORIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IONIZING RADIATION; PRIORITY JOURNAL; RISK ASSESSMENT; MORTALITY; NOTE; SURVIVAL RATE;

CAUSE OF DEATH; HODGKIN DISEASE; HUMANS; SURVIVAL RATE;

EID: 0142058028     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.07.001     Document Type: Editorial

References (17)

1. Peters MV: A study in survival of Hodgkin's disease treated radiologically. Am J Roentgenol Radium Ther 63:299-311, 1950
2. Kaplan HS: The radical radiotherapy of regionally localized Hodgkin's disease. Radiology 78:553-561, 1962
3. Kaplan HS: Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin's disease. Cancer Res 26:1221-1224, 1966
4. De Vita VT, Serpick A, Carbone PP: Combination chemotherapy in the treatment of Hodgkin's disease. Ann Intern Med 73:881-895, 1970
5. Diehl V, Sieber M, Ruffer U, et al: BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease-The German Hodgkin's Lymphoma Study Group. Ann Oncol 8:143-148, 1997
6. Diehl V, Franklin J, Hasenclever D, et al: BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 16:3810-3821, 1998
7. Bartlett NL, Rosenberg SA, Hoppe RT, et al: Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: A preliminary report. J Clin Oncol 13:1080-1088, 1995
8. Horning SJ, Hoppe RT, Breslin S, et al: Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. J Clin Oncol 20:630-637, 2002
9. Schmitz N, Pfistner B, Sextro M, et al: Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial. Lancet 359:2065-2071, 2002
10. Linch DC, Winfield D, Goldstone AH, et al: Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial. Lancet 341:1051-1054, 1993
11. Constans M, Sureda A, Terol MJ, et al: Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome. Ann Oncol 14:745-751, 2003
12. Aleman BMP, van den Belt-Dusebout AW, Klokman WJ, et al: Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21:3431-3439, 2003
13. Bonadonna G, Zucali R, Monfardini S, et al: Combination chemotherapy of Hodgkin's disease with Adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 36:252-259, 1975
14. Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478-1484, 1992
15. Duggan DB, Petroni GR, Johnson JL, et al: Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol 21:607-614, 2003
16. Valagussa P, Santoro A, Fossati-Bellani F, et al: Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4:830-837, 1986
17. Josting A, Wiedenmann S, Franklin J, et al: Secondary Myeloid Leukemia and Myelodysplastic Syndromes in Patients Treated for Hodgkin's Disease: A Report From the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:10.1200/JCO.2003.07.160